What are the ASH recommendation for treatment of immune thrombocytopenic purpura (ITP) during pregnancy?

Updated: Jun 28, 2019
  • Author: Craig M Kessler, MD, MACP; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print

Treatment considerations include the following:

  • Women with no bleeding manifestations and platelet counts ≥30 x 10 9/L do not require any treatment until 36 weeks’ gestation (sooner if delivery is imminent)
  • If platelet counts are < 30 x 10 9/L or clinically relevant bleeding is present, first-line therapy is oral corticosteroids or intravenous immunoglobulin (IVIg)
  • The recommended starting dose of IVIg is 1 g/kg
  • Prednisone and prednisolone are preferred to dexamethasone, which crosses the placenta more readily.
  • Recommended starting doses of prednisone by different experts vary from 0.25 to 0.5 to 1 mg/kg daily;no evidence exists that a higher starting dose is better
  • Medications are adjusted to maintain a safe platelet count

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!